Golden Ventures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Biossilbiossil.coApr 2026
biossil is an AI-native biopharma company developing late-stage drug programs for life-threatening conditions with unmet needs, including sickle cell disease, idiopathic pulmonary fibrosis, glioblastoma, breast cancer, and Alzheimer's disease.
AI & Machine LearningBiotechHealthtechToronto, CA
Alexander I. Mosa(MD PhD)Anthony Mouchantaf(JD MBA)
Co-investorsFounders FundPanache Ventures137 VenturesDRI HealthcareQuiet CapitalStaircase Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.